|
|||||||||||||
Alzheimer's disease is a devastating disorder of memory and thinking that affects not only those with the disease, but also their families and society as a whole. More than 4 million Americans suffer from Alzheimer disease and data from the Alzheimer’s Association indicate that currently there are 106,000 cases of Alzheimer disease in the State of Indiana with an anticipated growth of 54% by the year 2030. Although many advances have been made recently in the understanding of the causes, diagnosis, treatment, and genetics of Alzheimer's disease, much research remains to be done. The Indiana Alzheimer Disease Center is a National Institute on Aging
funded program whose purpose is to identify persons with probable Alzheimer
disease. Indiana University is one of 29 sites in the United States selected
to conduct such a program. The Indiana Alzheimer Disease Center is hosting the Symposia on Mild Cognitive Impairment Friday, April 18, and Saturday, April 19, at the Indiana Historical Society. The first day, specialists from across the country will focus on “Mild Cognitive Impairment: An Evolving Concept in Research and Clinical Practice.” This scientific program highlights current concepts in the diagnosis, genetics, imaging and therapy associated with mild cognitive impairment, a condition that affects one-fourth of Americans over the age of 65. The second day’s session is entitled “Mild Cognitive Impairment: Impact on the Patient and Family.” This is the Second Annual Martin Family Alzheimer Disease Symposium and is designed to inform the general public about the Indiana Alzheimer Disease Center and research in the area of mild cognitive impairment, as well as current best practice approaches to diagnosis, management and intervention. The courses are free but enrollment is limited. Registration, which is required, can be made through the Indiana University School of Medicine Division of Continuing Medical Education. |
|||||||||||||